Aaron Seth Kesselheim is a Visiting Associate Professor of Law at Yale Law School. He comes to Yale from Harvard Medical School, where he is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital (BWH). He leads the Program On Regulation, Therapeutics, and Law (PORTAL), an interdisciplinary research core focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law, and has published more than 150 articles on these and related topics in medical and health policy journals. He has testified before Congress on pharmaceutical policy and medical device regulation, and served as a consultant for the Institute of Medicine, ClinicalTrials.gov, USPTO, and numerous state government offices. He is a primary care internist at the Phyllis Jen Center for Primary Care at BWH, a member of the New York State Bar, and a patent attorney. Dr. Kesselheim’s recent work has been funded by the Greenwall Foundation Faculty Scholars in Bioethics program, the Agency for Healthcare Research and Quality, the FDA, and by a Robert Wood Johnson Investigator Award in Health Policy Research.
M.P.H., Harvard, 2007
J.D., University of Pennsylvania, 2002
M.D., University of Pennsylvania, 2002
A.B., Harvard, 1996
Food and Drug Administration Law